Pathophysiological profiling of vocal fold hyperkeratosis
声带角化过度的病理生理学分析
基本信息
- 批准号:10365122
- 负责人:
- 金额:$ 54.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-01 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAdjuvant TherapyAll-Trans-RetinolAmericanAreaBiological AssayBiological MarkersBiologyBiopsyCadaverCellsCellular biologyChemicalsChylomicronsClinicalClinical TrialsConsensusDataDietary intakeDilution TechniquesDiseaseDoseDysphoniaEpithelialEpithelial CellsExcisionExtrahepaticFamilyFibrosisFrequenciesFunctional disorderGoalsHealthHealth Care CostsHistopathologyHumanHyperkeratosisImpairmentInterventionIsotopesKeratinKineticsLarynxLasersLesionLeukoplakiaLiteratureLiverMeasuresMediatingMedicalMetabolismModelingMorbidity - disease rateMucous MembraneNatureNutrientOccupationalOperative Surgical ProceduresPatientsPerformancePractice GuidelinesQuality of lifeRattusRecurrenceResearchRetinoidsRetinol Binding ProteinsRiskSiteSocietiesSupplementationSurfaceTechniquesTestingTimeTissuesTranslational ResearchUnited StatesUnited States Food and Drug AdministrationVitamin AVitamin A DeficiencyVoiceanalogbasecandidate markerclinical applicationdietarydisorder controlexperimental studyiatrogenic injuryimprovedmolecular markermucosal uptakenovel markernovel strategiespre-clinicalpreservationregional differencestellate celltraffickinguptakevitamin A analogvocal cord
项目摘要
Project Summary/Abstract
Vocal fold (VF) hyperkeratosis – an accumulation of epithelial surface keratin resulting in clinical
leukoplakia – is primarily managed using destructive techniques that risk iatrogenic injury, fibrosis, and voice
impairment. Given the potential morbidity of biopsy and lesion removal, there is a compelling need for new
approaches to the workup and treatment of VF leukoplakic disorders that are non-destructive and grounded in
disease pathophysiology. In the current application, we propose translational research that will advance this
goal. Our preliminary data indicate that the essential nutrient vitamin A is a key regulator of epithelial health
and that systemic vitamin A deficiency can directly contribute to hyperkeratosis. Based on evidence of vitamin
A’s importance to VF stellate and epithelial cell biology, and its direct relevance to VF hyperkeratosis, we
propose three Specific Aims that will advance this research area towards greater clinical applicability by: (i)
assessing the systemic vitamin A status and lesion histopathology of patients with VF hyperkeratosis, and (ii)
examining vitamin A trafficking to, and uptake by, normal and hyperkeratotic VF mucosa in a rat model. Our
overarching goal is to determine if there is a pathophysiologic rationale for vitamin A supplementation in the
treatment of VF hyperkeratosis. Such a therapy would be transformative – both as a first-line approach for
patients who require conservative management, as well as an adjuvant therapy in patients for whom surgical
treatment is indicated.
项目总结/摘要
声带(VF)角化过度-上皮表面角蛋白的积聚导致临床
白斑病-主要使用破坏性技术进行治疗,有医源性损伤,纤维化和声音
损伤鉴于活检和病变切除的潜在发病率,迫切需要新的
检查和治疗VF白斑病的方法是非破坏性的,
疾病病理生理学在当前的应用中,我们提出了将推进这一点的转化研究
目标.我们的初步数据表明,必需营养素维生素A是上皮健康的关键调节因子,
并且全身性维生素A缺乏可直接导致角化过度。基于维生素的证据
A对VF星状细胞和上皮细胞生物学的重要性,以及它与VF角化过度的直接相关性,我们
提出了三个具体目标,将推动这一研究领域走向更大的临床适用性:(i)
评估VF角化过度患者的全身维生素A状态和病变组织病理学,以及(ii)
在大鼠模型中检查维生素A向正常和角化过度VF粘膜的运输和摄取。我们
首要目标是确定在糖尿病患者中补充维生素A是否有病理生理学依据。
VF角化过度的治疗。这种疗法将是变革性的--无论是作为一线治疗方法,
需要保守治疗的患者,以及需要手术治疗的患者的辅助治疗
治疗是指。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHERRY A TANUMIHARDJO其他文献
SHERRY A TANUMIHARDJO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHERRY A TANUMIHARDJO', 18)}}的其他基金
Pathophysiological profiling of vocal fold hyperkeratosis
声带角化过度的病理生理学分析
- 批准号:
10544046 - 财政年份:2022
- 资助金额:
$ 54.23万 - 项目类别:
Development of 13C-retinol isotope dilution techniques
13C-视黄醇同位素稀释技术的开发
- 批准号:
7060827 - 财政年份:2002
- 资助金额:
$ 54.23万 - 项目类别:
Development of 13C-retinol isotope dilution techniques
13C-视黄醇同位素稀释技术的开发
- 批准号:
6661087 - 财政年份:2002
- 资助金额:
$ 54.23万 - 项目类别:
Development of 13C-retinol isotope dilution techniques
13C-视黄醇同位素稀释技术的开发
- 批准号:
6506153 - 财政年份:2002
- 资助金额:
$ 54.23万 - 项目类别:
Development of 13C-retinol isotope dilution techniques
13C-视黄醇同位素稀释技术的开发
- 批准号:
6772417 - 财政年份:2002
- 资助金额:
$ 54.23万 - 项目类别:
相似海外基金
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 54.23万 - 项目类别:
The ESCAPE clinical trial of circulating tumor DNA to guide adjuvant therapy in chemo-resistant triple negative breast cancer
循环肿瘤 DNA 指导化疗耐药三阴性乳腺癌辅助治疗的 ESCAPE 临床试验
- 批准号:
494901 - 财政年份:2023
- 资助金额:
$ 54.23万 - 项目类别:
Operating Grants
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer
一项 I 型混合有效性实施试验,用于评估基于导航的多级干预措施,以减少头颈癌患者开始辅助治疗的延迟
- 批准号:
10714537 - 财政年份:2023
- 资助金额:
$ 54.23万 - 项目类别:
Multi-modal machine learning to guide adjuvant therapy in surgically resectable colorectal cancer
多模式机器学习指导可手术切除结直肠癌的辅助治疗
- 批准号:
10588103 - 财政年份:2023
- 资助金额:
$ 54.23万 - 项目类别:
Efficacy of ethanol adjuvant therapy after resection of malignant soft tissue tumors
恶性软组织肿瘤切除术后乙醇辅助治疗的疗效
- 批准号:
22K09407 - 财政年份:2022
- 资助金额:
$ 54.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of immune response cells and development of novel adjuvant therapy for sublingual immunotherapy
免疫应答细胞的鉴定和舌下免疫治疗新型辅助疗法的开发
- 批准号:
21KK0287 - 财政年份:2022
- 资助金额:
$ 54.23万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Pursuing molecular biomarkers to guide adjuvant therapy for HPV+ head and neck cancers after transoral robotic surgery
寻找分子生物标志物来指导经口机器人手术后 HPV 头颈癌的辅助治疗
- 批准号:
10357120 - 财政年份:2022
- 资助金额:
$ 54.23万 - 项目类别:
Biomarker research using two prospective studies on preoperative and postoperative adjuvant therapy for pancreatic cancer
使用两项关于胰腺癌术前和术后辅助治疗的前瞻性研究进行生物标志物研究
- 批准号:
21K08700 - 财政年份:2021
- 资助金额:
$ 54.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Personalized Resistant Starch as an Adjuvant Therapy for Pediatric Inflammatory Bowel Disease
个性化抗性淀粉作为小儿炎症性肠病的辅助治疗
- 批准号:
437315 - 财政年份:2020
- 资助金额:
$ 54.23万 - 项目类别:
Studentship Programs
Tailored adjuvant therapy in POLE-mutated and p53-wildtype early stage endometrial cancer (TAPER)
POLE 突变和 p53 野生型早期子宫内膜癌 (TAPER) 的定制辅助治疗
- 批准号:
435603 - 财政年份:2020
- 资助金额:
$ 54.23万 - 项目类别:
Operating Grants














{{item.name}}会员




